Lumos Pharma
Erik Brincks, PhD, has an extensive background in translational research, immunopharmacology, and immunology. With experience at University of Iowa, Trudeau Institute, University of Minnesota, NewLink Genetics, and currently at Lumos Pharma, Erik has held various roles such as Senior Director, Director, Senior Scientist, and Postdoctoral Associate. Erik obtained their PhD in Immunology from the University of Iowa in 2010.
This person is not in any offices
Lumos Pharma
1 followers
Lumos Pharma is a clinical-stage biopharmaceutical company whose mission is to develop new therapies for people with rare diseases, prioritizing its focus where the medical need is high, and the pathophysiology is clear.